| [1] |
Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
|
| [2] |
Du T,Chen J,Shen X.Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J].J China Pharm Univ(中国药科大学学报),2018,49(5):537-544.
|
| [3] |
Wu Y, Tang TT, Zhu QH, et al. Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro[J].J China Pharm Univ(中国药科大学学报),2018,49(3):348-353.
|
| [4] |
Chen X, Ba Y, Ma LJ, et al. Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Res,2008,18(10):997-1006.
|
| [5] |
van de Bunt M,Gaulton KJ,Parts L,et al.The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis[J].PLoS One,2013,8(1):e55272.
|
| [6] |
Esguerra JL,Bolmeson C,Cilio CM,et al.Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat[J].PLoS One,2011,6(4):e18613.doi: 10.1371/journal.pone.0018613.
|
| [7] |
El Ouaamari A,Baroukh N,Martens GA,et al.MiR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells[J].Diabetes,2008,57(10):2708-2717.
|
| [8] |
Tang XQ,Muniappan L,Tang GL,et al.Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription[J].RNA,2009,15(2):287-293.
|
| [9] |
Sun LL,Jiang BG,Li WT,et al.MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression[J].Diabetes Res Clin Pract,2011,91(1):94-100.
|
| [10] |
Sun D,Chen J,Wu W,et al.MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human[J].J Cell Mol Med,2019,23(4):2863-2871.
|
| [11] |
Kornfeld JW,Baitzel C,Könner AC,et al.Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b[J].Nature,2013,494(7435):111-115.
|
| [12] |
Zhang FF,Liu Y,Jin L.Mechanism of lncRNA-Pluto on promoting insulin biosynthesis and secretion[J].J China Pharm Univ(中国药科大学学报),2019,50(4):481-489.
|
| [13] |
Wang L,Coffinier C,Thomas MK,et al.Selective deletion of the Hnf1beta(MODY5)gene in beta-cells leads to altered gene expression and defective insulin release[J].Endocrinology,2004,145(8):3941-3949.
|
| [14] |
El-Khairi R,Vallier L.The role of hepatocyte nuclear factor 1β in disease and development[J].Diabetes Obes Metab,2016,18(Suppl 1):23-32.
|
| [15] |
Su SH,Wu GY,Cheng XD,et al.Oleanolic acid attenuates PCBs-induced adiposity and insulin resistance via HNF1b-mediated regulation of redox and PPAR signaling[J].Free Radic Biol Med,2018,124:122-134.
|
| [16] |
Clissold RL,Hamilton AJ,Hattersley AT,et al.HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum[J].Nat Rev Nephrol,2015,11(2):102-112.
|
| [17] |
Horikawa Y, Iwasaki N, Hara M, et al. Mutation in hepatocyte nuclear factor-1 beta gene(TCF2)associated with MODY[J].Nat Genet,1997,17(4):384-385.
|
| [18] |
Bellanné-Chantelot C,Chauveau D,Gautier JF,et al.Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations[J].Ann Intern Med,2004,140(7):510-517.
|
| [19] |
Haldorsen IS,Vesterhus M,Raeder H,et al.Lack of pancreatic body and tail in HNF1B mutation carriers[J].Diabet Med,2008,25(7):782-787.
|
| [20] |
Brackenridge A,Pearson ER,Shojaee-Moradie F,et al.Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and-1alpha mutations[J].Diabetes,2006,55(2):405-411.
|
| [21] |
Cebola I,Rodríguez-Seguí SA,Cho CH,et al.TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors[J].Nat Cell Biol,2015,17(5):615-626.
|
| [22] |
Panneerselvam A,Kannan A,Mariajoseph-Antony LF,et al.PAX proteins and their role in pancreas[J].Diabetes Res Clin Pract,2019,155:107792.
|
百度学术
下载:
